Bose S Kochupurakkal, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factor RelA | 1 | 2015 | 250 | 0.470 |
Why?
|
| Streptothricins | 1 | 2013 | 5 | 0.450 |
Why?
|
| Interferons | 2 | 2020 | 705 | 0.430 |
Why?
|
| Ovarian Neoplasms | 10 | 2021 | 4876 | 0.420 |
Why?
|
| Acetyltransferases | 1 | 2013 | 231 | 0.400 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2021 | 479 | 0.370 |
Why?
|
| Phthalazines | 3 | 2021 | 382 | 0.330 |
Why?
|
| Pyrazines | 4 | 2021 | 1198 | 0.290 |
Why?
|
| Pyrazoles | 4 | 2021 | 1988 | 0.280 |
Why?
|
| Myoblasts | 1 | 2007 | 232 | 0.270 |
Why?
|
| Transfection | 1 | 2013 | 5779 | 0.250 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11709 | 0.240 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 326 | 0.210 |
Why?
|
| DNA Repair | 4 | 2020 | 2038 | 0.210 |
Why?
|
| Epidermal Growth Factor | 2 | 2004 | 695 | 0.210 |
Why?
|
| Osteoblasts | 1 | 2007 | 1142 | 0.200 |
Why?
|
| Piperazines | 3 | 2021 | 2511 | 0.190 |
Why?
|
| Homeodomain Proteins | 2 | 2007 | 2413 | 0.190 |
Why?
|
| Osteogenesis | 1 | 2007 | 1271 | 0.180 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 9574 | 0.170 |
Why?
|
| Deoxycytidine | 2 | 2021 | 870 | 0.170 |
Why?
|
| Down-Regulation | 5 | 2015 | 2904 | 0.170 |
Why?
|
| Receptor, erbB-2 | 4 | 2013 | 2553 | 0.160 |
Why?
|
| Ataxia Telangiectasia | 1 | 2020 | 107 | 0.160 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2019 | 146 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2020 | 607 | 0.150 |
Why?
|
| Pyrimidinones | 1 | 2020 | 383 | 0.150 |
Why?
|
| BRCA2 Protein | 2 | 2020 | 798 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 5629 | 0.150 |
Why?
|
| Cisplatin | 2 | 2020 | 1645 | 0.150 |
Why?
|
| Fanconi Anemia | 1 | 2020 | 324 | 0.140 |
Why?
|
| DNA Replication | 2 | 2021 | 1410 | 0.140 |
Why?
|
| BRCA1 Protein | 3 | 2020 | 1147 | 0.140 |
Why?
|
| Cell Line | 4 | 2015 | 15591 | 0.140 |
Why?
|
| Ubiquitin | 3 | 2007 | 837 | 0.130 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 381 | 0.130 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2015 | 68 | 0.130 |
Why?
|
| Genes, BRCA2 | 2 | 2019 | 603 | 0.120 |
Why?
|
| Fallopian Tubes | 1 | 2015 | 178 | 0.120 |
Why?
|
| Intracellular Space | 1 | 2016 | 197 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 7403 | 0.120 |
Why?
|
| Genes, BRCA1 | 2 | 2019 | 765 | 0.120 |
Why?
|
| Hygromycin B | 1 | 2013 | 11 | 0.110 |
Why?
|
| Puromycin | 1 | 2013 | 42 | 0.110 |
Why?
|
| Neomycin | 1 | 2013 | 93 | 0.110 |
Why?
|
| CHO Cells | 3 | 2006 | 1389 | 0.110 |
Why?
|
| Cinnamates | 1 | 2013 | 59 | 0.110 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 655 | 0.110 |
Why?
|
| Breast Neoplasms | 6 | 2020 | 21017 | 0.110 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 116 | 0.110 |
Why?
|
| Cricetinae | 3 | 2006 | 2426 | 0.100 |
Why?
|
| Organoids | 1 | 2018 | 729 | 0.100 |
Why?
|
| Growth Substances | 2 | 2004 | 768 | 0.100 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 670 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2015 | 555 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2020 | 5249 | 0.100 |
Why?
|
| Zinc | 1 | 2016 | 687 | 0.100 |
Why?
|
| Thiazoles | 1 | 2019 | 1510 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 9273 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2015 | 8297 | 0.090 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 16886 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2013 | 23342 | 0.080 |
Why?
|
| Mutation | 6 | 2021 | 29915 | 0.070 |
Why?
|
| Ligands | 2 | 2004 | 3258 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3156 | 0.070 |
Why?
|
| Breast | 1 | 2015 | 1963 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10416 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2004 | 929 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2013 | 2472 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 2912 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2004 | 3680 | 0.060 |
Why?
|
| Lysosomes | 2 | 2007 | 919 | 0.060 |
Why?
|
| Ubiquitins | 1 | 2006 | 366 | 0.060 |
Why?
|
| DNA Damage | 3 | 2020 | 2439 | 0.060 |
Why?
|
| Mitogens | 1 | 2004 | 230 | 0.060 |
Why?
|
| Ultraviolet Rays | 2 | 2019 | 1076 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 3574 | 0.060 |
Why?
|
| Neuregulins | 1 | 2004 | 36 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2013 | 3602 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3664 | 0.050 |
Why?
|
| Humans | 26 | 2021 | 758406 | 0.050 |
Why?
|
| COS Cells | 1 | 2004 | 1128 | 0.050 |
Why?
|
| Introns | 1 | 2004 | 978 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 1693 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1991 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 11336 | 0.050 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.050 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2004 | 423 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 2013 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 3796 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 2262 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1262 | 0.040 |
Why?
|
| Female | 15 | 2021 | 390323 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2497 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10748 | 0.040 |
Why?
|
| Isoxazoles | 1 | 2021 | 230 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3783 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 2470 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 7590 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4169 | 0.040 |
Why?
|
| Animals | 9 | 2019 | 167768 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3617 | 0.040 |
Why?
|
| Exons | 1 | 2004 | 2387 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 1613 | 0.040 |
Why?
|
| Platinum | 1 | 2020 | 218 | 0.040 |
Why?
|
| Mitosis | 1 | 2004 | 1191 | 0.040 |
Why?
|
| Rabbits | 1 | 2004 | 4772 | 0.040 |
Why?
|
| Indazoles | 1 | 2020 | 302 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 735 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 327 | 0.040 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 480 | 0.040 |
Why?
|
| Phylogeny | 1 | 2004 | 2774 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8506 | 0.040 |
Why?
|
| Indolizines | 1 | 2016 | 30 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2004 | 2205 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2016 | 72 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 832 | 0.030 |
Why?
|
| Pyridinium Compounds | 1 | 2016 | 81 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 1477 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 1887 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2019 | 876 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2007 | 120 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3602 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 795 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 2825 | 0.030 |
Why?
|
| Oncogenes | 1 | 2021 | 1220 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 958 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2020 | 1085 | 0.030 |
Why?
|
| Carboplatin | 1 | 2018 | 788 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6068 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1825 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2019 | 1745 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2021 | 2020 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2016 | 532 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2020 | 960 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
| Mice | 5 | 2019 | 81101 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3774 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2016 | 324 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2007 | 11471 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 384 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 5779 | 0.030 |
Why?
|
| Computational Biology | 1 | 2004 | 3502 | 0.030 |
Why?
|
| Protein Binding | 1 | 2004 | 9311 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22032 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3527 | 0.020 |
Why?
|
| Genome | 1 | 2020 | 1739 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2001 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4106 | 0.020 |
Why?
|
| Piperidines | 1 | 2020 | 1639 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 2416 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 659 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11070 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1312 | 0.020 |
Why?
|
| Protein Transport | 2 | 2006 | 1963 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3442 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2379 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 9468 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4711 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11892 | 0.020 |
Why?
|
| Aged | 4 | 2021 | 168218 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2016 | 2930 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3432 | 0.020 |
Why?
|
| Models, Biological | 1 | 2004 | 9460 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 1360 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2013 | 1763 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3840 | 0.020 |
Why?
|
| Biotinylation | 1 | 2007 | 184 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64378 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4549 | 0.020 |
Why?
|
| Middle Aged | 4 | 2021 | 219568 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 4416 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29557 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 888 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58683 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 1840 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 4373 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5737 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 13447 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 877 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 670 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 13961 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2007 | 1647 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3609 | 0.010 |
Why?
|
| Male | 4 | 2021 | 358747 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 202 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 39872 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 868 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13245 | 0.010 |
Why?
|
| Ubiquitination | 1 | 2007 | 1006 | 0.010 |
Why?
|
| Genes | 1 | 2006 | 1845 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12759 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2006 | 3096 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9404 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11152 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16534 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 6036 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 2907 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39059 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18358 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 13591 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 219935 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4458 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 6127 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 2443 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18119 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12604 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 58808 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4485 | 0.010 |
Why?
|
| Child | 1 | 2019 | 79818 | 0.010 |
Why?
|
| Glioma | 1 | 2004 | 3418 | 0.000 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 5246 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2006 | 12094 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 8981 | 0.000 |
Why?
|